576 related articles for article (PubMed ID: 34719438)
1. Diagnostic criteria for enduring sexual dysfunction after treatment with antidepressants, finasteride and isotretinoin.
Healy D; Bahrick A; Bak M; Barbato A; Calabrò RS; Chubak BM; Cosci F; Csoka AB; D'Avanzo B; Diviccaro S; Giatti S; Goldstein I; Graf H; Hellstrom WJG; Irwig MS; Jannini EA; Janssen PKC; Khera M; Kumar MT; Le Noury J; Lew-Starowicz M; Linden DEJ; Lüning C; Mangin D; Melcangi RC; Rodríguez OWMAAS; Panicker JN; Patacchini A; Pearlman AM; Pukall CF; Raj S; Reisman Y; Rubin RS; Schreiber R; Shipko S; Vašečková B; Waraich A
Int J Risk Saf Med; 2022; 33(1):65-76. PubMed ID: 34719438
[TBL] [Abstract][Full Text] [Related]
2. Enduring sexual dysfunction after treatment with antidepressants, 5α-reductase inhibitors and isotretinoin: 300 cases.
Healy D; Le Noury J; Mangin D
Int J Risk Saf Med; 2018; 29(3-4):125-134. PubMed ID: 29733030
[TBL] [Abstract][Full Text] [Related]
3. Post-finasteride syndrome and post-SSRI sexual dysfunction: two sides of the same coin?
Giatti S; Diviccaro S; Panzica G; Melcangi RC
Endocrine; 2018 Aug; 61(2):180-193. PubMed ID: 29675596
[TBL] [Abstract][Full Text] [Related]
4. One hundred and twenty cases of enduring sexual dysfunction following treatment.
Hogan C; Le Noury J; Healy D; Mangin D
Int J Risk Saf Med; 2014; 26(2):109-16. PubMed ID: 24902508
[TBL] [Abstract][Full Text] [Related]
5. Post-SSRI Sexual Dysfunction (PSSD): Biological Plausibility, Symptoms, Diagnosis, and Presumed Risk Factors.
Peleg LC; Rabinovitch D; Lavie Y; Rabbie DM; Horowitz I; Fruchter E; Gruenwald I
Sex Med Rev; 2022 Jan; 10(1):91-98. PubMed ID: 34627736
[TBL] [Abstract][Full Text] [Related]
6. Post-SSRI Sexual Dysfunction: A Literature Review.
Bala A; Nguyen HMT; Hellstrom WJG
Sex Med Rev; 2018 Jan; 6(1):29-34. PubMed ID: 28778697
[TBL] [Abstract][Full Text] [Related]
7. Selective serotonin reuptake inhibitors, post-treatment sexual dysfunction and persistent genital arousal disorder: A systematic review.
Tarchi L; Merola GP; Baccaredda-Boy O; Arganini F; Cassioli E; Rossi E; Maggi M; Baldwin DS; Ricca V; Castellini G
Pharmacoepidemiol Drug Saf; 2023 Oct; 32(10):1053-1067. PubMed ID: 37294623
[TBL] [Abstract][Full Text] [Related]
8. Characterizing post-SSRI sexual dysfunction and its impact on quality of life through an international online survey.
Studt A; Gannon M; Orzel J; Vaughan A; Pearlman AM
Int J Risk Saf Med; 2021; 32(4):321-329. PubMed ID: 34366299
[TBL] [Abstract][Full Text] [Related]
9. Selective serotonin reuptake inhibitor-induced sexual dysfunction.
Corona G; Ricca V; Bandini E; Mannucci E; Lotti F; Boddi V; Rastrelli G; Sforza A; Faravelli C; Forti G; Maggi M
J Sex Med; 2009 May; 6(5):1259-69. PubMed ID: 19473282
[TBL] [Abstract][Full Text] [Related]
10. The pathophysiology of Post SSRI Sexual Dysfunction - Lessons from a case study.
Klaas S; Siva JB; Bak M; Govers M; Schreiber R
Biomed Pharmacother; 2023 May; 161():114166. PubMed ID: 36898260
[TBL] [Abstract][Full Text] [Related]
11. Persistent genital arousal disorder in women: case reports of association with anti-depressant usage and withdrawal.
Leiblum SR; Goldmeier D
J Sex Marital Ther; 2008; 34(2):150-9. PubMed ID: 18224549
[TBL] [Abstract][Full Text] [Related]
12. A clinical review of antidepressants, their sexual side-effects, post-SSRI sexual dysfunction, and serotonin syndrome.
Marks S
Br J Nurs; 2023 Jul; 32(14):678-682. PubMed ID: 37495413
[TBL] [Abstract][Full Text] [Related]
13. Sexual Consequences of Post-SSRI Syndrome.
Reisman Y
Sex Med Rev; 2017 Oct; 5(4):429-433. PubMed ID: 28642048
[TBL] [Abstract][Full Text] [Related]
14. Exposure to serotonin selective reuptake inhibitors or serotonin noradrenaline reuptake inhibitors and sexual dysfunction: Results from an online survey.
Patacchini A; Cosci F
Int J Risk Saf Med; 2021; 32(3):229-242. PubMed ID: 33579876
[TBL] [Abstract][Full Text] [Related]
15. Post-Finasteride Syndrome And Post-Ssri Sexual Dysfunction: Two Clinical Conditions Apparently Distant, But Very Close.
Giatti S; Diviccaro S; Cioffi L; Cosimo Melcangi R
Front Neuroendocrinol; 2024 Jan; 72():101114. PubMed ID: 37993021
[TBL] [Abstract][Full Text] [Related]
16. Post-SSRI sexual dysfunction & other enduring sexual dysfunctions.
Healy D
Epidemiol Psychiatr Sci; 2019 Sep; 29():e55. PubMed ID: 31543091
[TBL] [Abstract][Full Text] [Related]
17. Persistent sexual dysfunction after SSRI withdrawal: a scoping review and presentation of 86 cases from the Netherlands.
Chinchilla Alfaro K; van Hunsel F; Ekhart C
Expert Opin Drug Saf; 2022 Apr; 21(4):553-561. PubMed ID: 34791958
[TBL] [Abstract][Full Text] [Related]
18. Post-SSRI sexual dysfunction: Patient experiences of engagement with healthcare professionals.
Healy D; Le Noury J; Mangin D
Int J Risk Saf Med; 2019; 30(3):167-178. PubMed ID: 31450514
[TBL] [Abstract][Full Text] [Related]
19. Post-SSRI Sexual Dysfunction: Clinical Characterization and Preliminary Assessment of Contributory Factors and Dose-Response Relationship.
Ben-Sheetrit J; Aizenberg D; Csoka AB; Weizman A; Hermesh H
J Clin Psychopharmacol; 2015 Jun; 35(3):273-8. PubMed ID: 25815755
[TBL] [Abstract][Full Text] [Related]
20. [Major depressive disorder, antidepressants and sexual dysfunction].
Kinzl JF
Neuropsychiatr; 2009; 23(2):134-8. PubMed ID: 19573505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
